Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK [IMGN632]) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Beijing 302 Hospital
First People's Hospital of Hangzhou
H. Lee Moffitt Cancer Center and Research Institute
Medical College of Wisconsin
Dana-Farber Cancer Institute
City of Hope Medical Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
University of Alabama at Birmingham
Fred Hutchinson Cancer Center
Dartmouth-Hitchcock Medical Center
City of Hope Medical Center
Washington University School of Medicine
St. Jude Children's Research Hospital
City of Hope Medical Center
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
Washington University School of Medicine
M.D. Anderson Cancer Center
Children's Hospital Medical Center, Cincinnati
Fred Hutchinson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
University of Maryland, Baltimore
Memorial Sloan Kettering Cancer Center
The First Affiliated Hospital of Xiamen University
Northwestern University
Nanfang Hospital, Southern Medical University
Beijing 302 Hospital
Shanxi Bethune Hospital
Medical College of Wisconsin
Children's Hospital of Soochow University
Medical College of Wisconsin
The Second People's Hospital of Huai'an
University of Nebraska
M.D. Anderson Cancer Center
Milton S. Hershey Medical Center
University of Washington
M.D. Anderson Cancer Center
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias
The First Affiliated Hospital with Nanjing Medical University
The First Affiliated Hospital of Soochow University
University of Kentucky
Washington University School of Medicine
M.D. Anderson Cancer Center
Virginia Commonwealth University
Shengjing Hospital